The mRNA and protein levels of p53 and p21 were upregulated, and Cyclin B1, CDK1, Cyclin A2 and CDK2 were significantly downregulated in NSCLC cells following CHEPS treatment for 48 h. This evidence concerns the gene TP53 and non-small cell lung carcinoma.